Advertisement
Screener

Eton Pharmaceuticals, Inc. (ETON) Net Margin

Eton Pharmaceuticals, Inc. (ETON) Net Margin

  • 2026-06-30: Net Margin 30.80%.
  • 2026-03-31: Net Margin 6.40%.
  • 2025-12-31: Net Margin 6.97%.
  • 2025-09-30: Net Margin -8.58%.

Complete source-backed net margin history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3030.80%
2026-03-316.40%
2025-12-316.97%
2025-09-30-8.58%
2025-06-30-13.66%
2025-03-31-9.10%
2024-12-31-5.13%
2024-09-306.07%
2024-06-30-33.51%
2024-03-31-10.18%
2023-12-31-30.85%
2023-09-30-8.24%
2023-06-3038.00%
2023-03-31-50.15%
2022-12-3110.73%
2022-09-30-94.59%
2022-06-30-21.17%
2022-03-31-244.94%
2021-12-3117.05%
2021-09-30-786.32%
2021-06-30-65.73%
2021-03-3143.00%
2020-12-31-9490.12%
2020-09-304039.75%
2020-06-30-23650.00%
2020-03-31-9140.40%
2019-12-31-587.36%
2019-03-31-1482.00%

Annual Net Margin

DateNet Margin
2025-12-31-5.75%
2024-12-31-9.80%
2023-12-31-2.96%
2022-12-31-42.45%
2021-12-31-8.95%
2020-12-31-71717.95%
2019-12-31-1910.32%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xencor Inc (XNCR)United States$1.776B-7.33
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Septerna, Inc. (SEPN)United States$1.783B-63.01
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20